Mesalamine

Overview

Mesalamine is an anti-inflammatory drug used to treat inflammatory bowel diseases, such as ulcerative colitis. It works by inhibiting the production of substances in the lining of the colon that cause inflammation.

API suppliers (27)

Suppliers of Mesalamine evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• ERREGIERRE SPAItaly2 active DMF GMP on record
• Zydus Lifesciences LimitedIndia2 active DMF GMP on record
• Sun Pharmaceutical Industries LimitedIndia1 active DMF GMP on record
• Ipca Laboratories LimitedIndia1 active DMF GMP on record
• MATRIX PHARMACORP PRIVATE LTDIndia1 active DMF
• AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)India1 active DMF
• OPTIMUS DRUGS PRIVATE LTDIndia1 active DMF
• Zhejiang Hengkang Pharmaceutical Co., Ltd.China1 active DMF GMP on record
• DASAMI LAB PRIVATE LTDIndia1 active DMF GMP on record
• Iol Chemicals And Pharmaceuticals LimitedIndia1 active DMF GMP on record
• MSN LIFE SCIENCES PRIVATE LIMITEDIndia1 active DMF GMP on record
• CHEMI SPAItaly1 active DMF GMP on record
• ALP PHARM BEIJING CO LTD1 active DMF
• SOLARA ACTIVE PHARMA SCIENCES LTDIndia1 active DMF GMP on record
• CTX LIFE SCIENCES PVT LTDIndia1 active DMF
• Divis LaboratoriesIndia1 active DMF GMP on record
• MAITHRI DRUGS PRIVATE LTDIndia1 active DMF GMP on record
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
• Alkem Laboratories LimitedIndia1 active DMF GMP on record
• Lupin LimitedIndia GMP on record
• BEC CHEMICALS PRIVATE LTD
• DR REDDYS LABORATORIES LTD GMP on record
• CORDEN PHARMA BERGAMO SPAItaly GMP on record
• SIGNA SA DE CV
• SIMS SRLUnited States

Showing 25 of 27 suppliers — see the full list in the app.

Patent & exclusivity (US)

Per the FDA Orange Book (39 approved US products), the latest listed US patent on Mesalamine expires 1 May 2030. Generic API sourcing typically opens up once these lapse.

Therapeutic areas